Health
AstraZeneca U.S. COVID-19 vaccine trial results likely in late-January, says health official – Reuters
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief…
By Reuters Staff
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. governments Operation Warp Speed program said on Wednesday.
The British drugmaker…
-
Noosa News23 hours agoUniversity of Queensland researchers survey population of endangered White’s Seahorse
-
Noosa News23 hours agoSA landscape boards crack down on illegal dams in Mount Lofty Ranges
-
General22 hours agoMontana’s house was gutted by an accidental fire. Then her landlord accused her of starting it
-
Business22 hours agoThe smartest ASX dividend stocks to buy with $5,000 right now